Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1004316-91-9

(alphaS)-alpha-[[[Methyl[[2-(1-Methylethyl)-4-thiazolyl]Methyl]aMino]carbonyl]aMino]-4-Morpholinebutanoic acid Methyl ester, commonly known as Moxifloxacin, is a synthetic fluoroquinolone antibacterial agent. It is characterized by its ability to inhibit bacterial DNA gyrase and topoisomerase IV enzymes, which are crucial for bacterial DNA replication, transcription, repair, and recombination. This action leads to the death of bacteria and halts the spread of infections.

1004316-91-9 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

  • High purity (alphaS)-alpha-[[[Methyl[[2-(1-methylethyl)-4-thiazolyl]methyl]amino]carbonyl]amino]-4-morpholinebutanoic acid methyl ester CAS No.:1004316-91-9

    Cas No: 1004316-91-9

  • USD $ 2.0-2.0 / Kilogram

  • 1 Kilogram

  • 10 Metric Ton/Month

  • Hangzhou Think Chemical Co. Ltd
  • Contact Supplier

  • C18H30N4O4S (alphaS)-alpha-[[[Methyl[[2-(1-Methylethyl)-4-thiazolyl]Methyl]aMino]carbonyl]aMino]-4-Morpholinebutanoic acid Methyl ester 1004316-91-9

    Cas No: 1004316-91-9

  • No Data

  • 1 Metric Ton

  • 100 Metric Ton/Day

  • HENAN NEW BLUE CHEMICAL CO.,LTD
  • Contact Supplier

  • (alphaS)-alpha-[[[Methyl[[2-(1-methylethyl)-4-thiazolyl]methyl]amino]carbonyl]amino]-4-morpholinebutanoic acid methyl ester

    Cas No: 1004316-91-9

  • USD $ 1.9-2.9 / Gram

  • 100 Gram

  • 1000 Metric Ton/Month

  • Chemlyte Solutions
  • Contact Supplier

  • (alphaS)-alpha-[[[Methyl[[2-(1-Methylethyl)-4-thiazolyl]Methyl]aMino]carbonyl]aMino]-4-Morpholinebutanoic acid Methyl ester with high quality/best price/manufacturer

    Cas No: 1004316-91-9

  • No Data

  • 10 Gram

  • 200 Kilogram/Month

  • Hubei Jusheng Technology Co., Ltd.,
  • Contact Supplier

  • (alphaS)-alpha-[[[Methyl[[2-(1-methylethyl)-4-thiazolyl]methyl]amino]carbonyl]amino]-4-morpholinebutanoic acid methyl ester

    Cas No: 1004316-91-9

  • No Data

  • No Data

  • No Data

  • Skyrun Industrial Co.,Ltd
  • Contact Supplier
  • 1004316-91-9 Structure

  • Basic information

    1. Product Name: (alphaS)-alpha-[[[Methyl[[2-(1-Methylethyl)-4-thiazolyl]Methyl]aMino]carbonyl]aMino]-4-Morpholinebutanoic acid Methyl ester
    2. Synonyms: (alphaS)-alpha-[[[Methyl[[2-(1-Methylethyl)-4-thiazolyl]Methyl]aMino]carbonyl]aMino]-4-Morpholinebutanoic acid Methyl ester
    3. CAS NO:1004316-91-9
    4. Molecular Formula: C18H30N4O4S
    5. Molecular Weight: 398.5202
    6. EINECS: 1312995-182-4
    7. Product Categories: N/A
    8. Mol File: 1004316-91-9.mol

  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: N/A
    3. Flash Point: N/A
    4. Appearance: /
    5. Density: N/A
    6. Refractive Index: N/A
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. CAS DataBase Reference: (alphaS)-alpha-[[[Methyl[[2-(1-Methylethyl)-4-thiazolyl]Methyl]aMino]carbonyl]aMino]-4-Morpholinebutanoic acid Methyl ester(CAS DataBase Reference)
    10. NIST Chemistry Reference: (alphaS)-alpha-[[[Methyl[[2-(1-Methylethyl)-4-thiazolyl]Methyl]aMino]carbonyl]aMino]-4-Morpholinebutanoic acid Methyl ester(1004316-91-9)
    11. EPA Substance Registry System: (alphaS)-alpha-[[[Methyl[[2-(1-Methylethyl)-4-thiazolyl]Methyl]aMino]carbonyl]aMino]-4-Morpholinebutanoic acid Methyl ester(1004316-91-9)

  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 1004316-91-9(Hazardous Substances Data)

1004316-91-9 Usage

Uses

Used in Pharmaceutical Industry:
Moxifloxacin is used as an antibacterial agent for treating various bacterial infections, including sinusitis, pneumonia, and skin infections. Its application is based on its effectiveness in inhibiting essential bacterial enzymes, thereby preventing the growth and spread of bacteria.
Used in Oral and Intravenous Formulations:
Moxifloxacin is available in both oral and intravenous formulations, allowing for flexible treatment options depending on the severity and nature of the infection. Its use in these formulations is due to its well-tolerated nature and the convenience it offers for patients and healthcare providers.
While the provided materials do not explicitly list different applications in various industries, the primary use of Moxifloxacin is in the pharmaceutical industry for medical treatment. However, it is important to note that the potential side effects, such as nausea, dizziness, and diarrhea, should be considered when prescribing and administering this medication.

Check Digit Verification of cas no

The CAS Registry Mumber 1004316-91-9 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,0,4,3,1 and 6 respectively; the second part has 2 digits, 9 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 1004316-91:
(9*1)+(8*0)+(7*0)+(6*4)+(5*3)+(4*1)+(3*6)+(2*9)+(1*1)=89
89 % 10 = 9
So 1004316-91-9 is a valid CAS Registry Number.

1004316-91-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 13, 2017

Revision Date: Aug 13, 2017

1.Identification

1.1 GHS Product identifier

Product name methyl (S)-2-(3-((2-isopropylthiazol-4-yl)methyl)-3-methylureido)-4-morpholinobutanoate

1.2 Other means of identification

Product number -
Other names (alphaS)-alpha-Methyl2-(1-methylethyl)-4-thiazolylmethylaminocarbonylamino-4-morpholinebutanoicacidmethylester

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:1004316-91-9 SDS

1004316-91-9Relevant articles and documents

METHODS AND INTERMEDIATES FOR PREPARING PHARMACEUTICAL AGENTS

-

, (2013/08/15)

Methods and intermediates useful for preparing a compound of formula I and salts thereof.

MODULATORS OF PHARMACOKINETIC PROPERTIES OF THERAPEUTICS

-

Page/Page column 217-218, (2008/06/13)

The present application provides for a compound of Formula I, or a pharmaceutically acceptable salt, solvate, and/or ester thereof, compositions containing such compounds, therapeutic methods that include the administration of such compounds, and therapeutic methods and include the administration of such compounds with at least one additional therapeutic agent.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1004316-91-9